Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer

BACKGROUND: Chemoradiotherapy (CRT) is the standard treatment for patients with inoperable stage III non‐small cell lung cancer (NSCLC) stage III. With a median OS beyond 30 months, adequate pulmonary function (PF) is essential to ensure acceptable quality of life after treatment. Forced expiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Grambozov, Brane, Wolf, Frank, Kaiser, Julia, Wass, Romana, Fastner, Gerd, Gaisberger, Christoph, Rettenbacher, Lukas, Studnicka, Michael, Pirich, Christian, Sedlmayer, Felix, Zehentmayr, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996983/
https://www.ncbi.nlm.nih.gov/pubmed/31855325
http://dx.doi.org/10.1111/1759-7714.13276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996983/
https://www.ncbi.nlm.nih.gov/pubmed/31855325
http://dx.doi.org/10.1111/1759-7714.13276

Ejemplares similares